Rick Silva

New Capabilities

Described the trial design and regulatory path in the university's release

The FDA cleared Wave Neuroscience's personalized magnetic brain therapy for PTSD on June 3, 2026. The clinical summary filed with the decision, K260402, reports that 68.2% of treated patients were in remission two to four months after treatment.

Updated Oct 27